Valsartan And Hydrochlorothiazide Tablet
Product Images NDC 82868-054

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 82868-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82868-054-30 (82868 054 30 Rev A 05 24)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, with strengths of 160 mg and 25 mg. The label states it contains 30 tablets for oral use, marked Rx only. It includes storage instructions and manufacturer details, Northwind Pharmaceuticals, repackaged by Macleods Pharma USA Inc.*

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

A line graph depicting the percentage of patients with systolic blood pressure (SBP) under 140 mmHg versus baseline SBP (mmHg). Four treatment groups are compared: Valsartan HCT 320/25 mg (dots), Valsartan 320 mg (triangles), Hydrochlorothiazide 25 mg (squares), and placebo (crosses). The graph shows the percentage decreasing as baseline SBP increases, with Valsartan HCT having the highest percentage below 140 mmHg.*

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

A line graph comparing the percentage of patients achieving diastolic blood pressure under 90 mmHg (% DBP <90) against baseline diastolic blood pressure (DBP in mmHg). The graph shows four lines representing Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating their relative efficacy in lowering DBP.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

A line graph showing the percentage of subjects with systolic blood pressure below 130 mmHg (% SBP <130) plotted against baseline systolic blood pressure (SBP) readings from 140 to 180 mmHg. Four data series are depicted: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, each represented by distinct symbols in the legend.*

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

A line graph displaying the percentage of diastolic blood pressure (DBP) below 80 mmHg against baseline DBP values (90 to 110 mmHg). The graph compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, each represented by distinct markers in the legend.*

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

Chemical structure of Valsartan and Hydrochlorothiazide, illustrating the molecular configuration of these active ingredients in the prescription drug combination.*

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

Chemical structure diagram of valsartan, a component of the combination drug Valsartan and Hydrochlorothiazide. The diagram shows molecular bonds and atoms including carbon, hydrogen, nitrogen, and oxygen in the valsartan molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.